Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05578781 · ClinicalTrials.gov registry record · NA

Music-based Treatments and Pain: Underlying Mechanisms and the Beneficial Effects of Music-Based Treatments

A NA study, sponsored by University of Washington.

Completed
Registry status
NA
Development phase
99
Enrollment target

NCT05578781: Completed NA study, sponsored by University of Washington.

NCT05578781 is a NA study that has completed, run by University of Washington. The registered enrollment target is 99 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05578781, a NA study, has completed, sponsored by University of Washington.

COMPLETED
Registry status
NA
Development phase
99 participants
Enrollment target

Study Summary

The purpose of this study is to understand the mechanisms that underlie the beneficial effects of music-based treatments in individuals with moderate to severe chronic low back pain

Primary Outcome

Frontal midline theta power will be assessed using EEG assessment measuring brain oscillation spectral power for 5-min before and during each 20-min session.

Interventions

  • BEHAVIORAL Control group
  • BEHAVIORAL Music Therapy
  • BEHAVIORAL Music Medicine

Trial Details

FieldValue
Enrollment Target 99 participants
Start Date 2023-01-26
Est. Completion 2024-11-14
Phase NA
University of Washington

1,048 total trials

What the finished NCT05578781 record still lists

NCT05578781 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 99 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).

The record links to 0 conditions, and to 3 interventions - of which Control group is the first listed.

NCT05578781 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05578781 about?

NCT05578781 is a clinical study titled "Music-based Treatments and Pain: Underlying Mechanisms and the Beneficial Effects of Music-Based Treatments". The purpose of this study is to understand the mechanisms that underlie the beneficial effects of music-based treatments in individuals with moderate to severe chronic low back pain

What is the current status of trial NCT05578781?

This trial is currently completed. It is a NA study. The enrollment target is 99 participants. The study started on 2023-01-26. Estimated completion is 2024-11-14.

What interventions are being tested in trial NCT05578781?

The interventions under investigation include: Control group (BEHAVIORAL), Music Therapy (BEHAVIORAL), Music Medicine (BEHAVIORAL).

Who is sponsoring clinical trial NCT05578781?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05578781's enrollment target sits among peer trials

99 920th of 2000 higher than 1,079 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03965234 · 99 participants · Phase 1

    Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases

  • NCT04022616 · 99 participants

    Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients

  • NCT04042844 · 99 participants · Phase 2

    A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)

  • NCT04143724 · 99 participants · Phase 2

    Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05578781, the US trial registry maintained by the National Library of Medicine. NCT05578781 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.